Why Payers Lag Drug Developers and Regulators in Embracing Real-World Evidence
Catch Meg Alexander, Head, Reputation & Risk Management Practice at Syneos Health, on RARECast – a podcast focused on the intersection of rare disease with business, science, and policy.